Olaparib

Active Ingredient: Olaparib
Form: Oral tablet
Brand Name: Lynparza
Generic Name: Olakin
Generic Manufacturer: Ziska Pharmaceuticals

Indications:
Lynparza is indicated for the treatment of HER2-negative metastatic breast cancer patients with a confirmed or suspected harmful BRCA mutation, and as maintenance therapy in patients with platinum-sensitive relapsed high-grade ovarian, fallopian tube, or primary peritoneal cancer who have responded to prior platinum-based chemotherapy.

Dosage and Administration:
The recommended dose is 800 mg per day, taken in two divided doses. If a dose is missed, continue with the next scheduled dose. Dosage adjustments may be required to manage side effects, as directed by a physician.

Common Side Effects:
Serious side effects may include anemia and thrombocytopenia, which may lead to discontinuation in some patients.

Storage:
Store below 30°C in a cool, dry place away from light. Keep out of reach of children.

Frequently Asked Questions

Q: What is the relationship between Lynparza and Olaparib?
A: Lynparza is the brand name registered by the original manufacturer. Olaparib is its active ingredient.

Q: Is the Lynparza sold by Mediva Rx the original brand-name drug?
A: No. Mediva Rx provides a high-quality generic version manufactured by one of Bangladesh’s top 10 pharmaceutical companies. It contains the same active ingredient and therapeutic effect as the original drug, and is tested and approved by the Directorate General of Drug Administration (DGDA).

Q: Is the manufacturer of the Lynparza generic reliable?
A: Yes. We work with Ziska Pharmaceuticals, one of Bangladesh’s leading pharmaceutical manufacturers. They operate in-house R&D, production, and quality control labs, and are internationally certified for Good Manufacturing Practice (GMP). You can purchase with confidence.

Disclaimer:
This information is for reference only. Please consult your physician and refer to the official medication guide and the latest medical research before making treatment decisions.

Drug Instructions (Package Insert):
Download Link